NEPH Nephros Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEPH

Price (delayed)

$3.24

Market cap

$35.19M

P/E Ratio

21.6

Dividend/share

N/A

EPS

$0.15

Enterprise value

$31.36M

?
Relative Growth: Rel. Growth: 84
Relative Strength: Rel. Strength: 31
Relative Valuation: Rel. Valuation: 60
Relative Profitability: Rel. Profitability: 79

Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an ...

Highlights
The EPS has soared by 150% from the previous quarter and by 15% YoY
Nephros's net income has soared by 124% from the previous quarter and by 31% YoY
The company's gross margin fell by 3.3% YoY but it rose by 2.3% QoQ
The company's quick ratio fell by 34% YoY and by 12% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.nephros.com
Peers: RMTI BSX TMO DHR

Key stats

What are the main financial stats of NEPH

NEPH stock price

How has the Nephros stock price performed over time
Intraday
0%
1 week
-7.69%
1 month
-11.72%
1 year
-39.66%
YTD
-33.61%
QTD
-12.67%

Financial performance

How have Nephros's revenue and profit performed over time
Revenue
$20.72M
Gross profit
$12.7M
Operating income
$1.64M
Net income
$1.74M
Gross margin
61.3%
Net margin
8.4%
The company's operating income has surged by 143% QoQ and by 23% YoY
The operating margin has soared by 126% QoQ
Nephros's net income has soared by 124% from the previous quarter and by 31% YoY
The company's net margin has surged by 105% QoQ and by 5% YoY

Price vs fundamentals

How does NEPH's price correlate with its fundamentals

Growth

What is Nephros's growth rate over time

Valuation

What is Nephros stock price valuation
P/E
21.6
P/B
2.94
P/S
1.7
EV/EBIT
17.89
EV/EBITDA
16.74
EV/Sales
1.51
The EPS has soared by 150% from the previous quarter and by 15% YoY
NEPH's P/E is 43% below its last 4 quarters average of 37.9
NEPH's price to book (P/B) is 28% less than its last 4 quarters average of 4.1 and 2% less than its 5-year quarterly average of 3.0
Nephros's equity has increased by 25% YoY and by 12% QoQ
The price to sales (P/S) is 26% lower than the last 4 quarters average of 2.3 and 15% lower than the 5-year quarterly average of 2.0
The revenue has grown by 24% YoY and by 8% from the previous quarter

Efficiency

How efficient is Nephros business performance
The ROE has soared by 110% from the previous quarter and by 9% YoY
The return on assets has surged by 108% since the previous quarter and by 6% year-on-year
The ROS has soared by 107% from the previous quarter and by 4.9% YoY
Nephros's ROIC has soared by 104% from the previous quarter and by 26% YoY

Dividends

What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEPH.

Financial health

How did Nephros financials performed over time
The total liabilities rose by 44% YoY and by 23% QoQ
The company's quick ratio fell by 34% YoY and by 12% QoQ
The company's debt is 93% lower than its equity
The debt to equity has declined by 46% year-on-year and by 22% since the previous quarter
The company's debt fell by 30% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.